The U.S. Food and Drug Administration has approved a subcutaneous induction regimen for risankizumab-rzaa for adults with moderately to severely active Crohn's disease.
The U.S. Food and Drug Administration has approved a subcutaneous induction regimen for risankizumab-rzaa for adults with moderately to severely active Crohn's disease.
Dr Schwartz discusses his presentation on the evaluation and management of perianal fistulizing Crohn's disease from the ACG Scientific Meeting, including review of results from studies of guselkumab, upadacitinib, and vedolizumab as...
Dr Schwartz discusses his presentation on the evaluation and management of perianal fistulizing Crohn's disease from the ACG Scientific Meeting, including review of results from studies of guselkumab, upadacitinib, and vedolizumab as...
Dr Cross reviews his presentation at the ACG Postgraduate Course on the diagnosis and management of fibrostenotic strictures in Crohn's disease, including options for medical, endoscopic, and surgical treatment.
Dr Cross reviews his presentation at the ACG Postgraduate Course on the diagnosis and management of fibrostenotic strictures in Crohn's disease, including options for medical, endoscopic, and surgical treatment.
Drs Corey Siegel and Gil Melmed discuss results of a survey of patients with ileocolic Crohn's disease that revealed roughly equal numbers would participate in a patient preference design study in which they could choose whether to receive...
Drs Corey Siegel and Gil Melmed discuss results of a survey of patients with ileocolic Crohn's disease that revealed roughly equal numbers would participate in a patient preference design study in which they could choose whether to receive...
Drs Corey Siegel and Gil Melmed...
10/11/2026
Advances in Inflammatory Bowel Disease Network
About Us
The Advances in Inflammatory Bowel Disease Network provides gastroenterology professionals with a central source for the wealth of content on IBD—articles, abstracts, videos, podcasts, and commentary—generated at our regional and annual meetings.
Drs Adam Faye and Raymond Cross discuss the particular issues to consider when treating patients who are older, obese, or frail, as well as patients with a history of or current cancer or heart disease.
Drs Adam Faye and Raymond Cross discuss the particular issues to consider when treating patients who are older, obese, or frail, as well as patients with a history of or current cancer or heart disease.
Hosts Raymond Cross, MD, and Sara Horst, MD, have a frank discussion about the extent of burnout among physicians—including gastroenterologists—including causes, and advice on how to better manage time and work-life balance.
Hosts Raymond Cross, MD, and Sara Horst, MD, have a frank discussion about the extent of burnout among physicians—including gastroenterologists—including causes, and advice on how to better manage time and work-life balance.
Host Raymond Cross, MD, and colorectal surgeon Rebecca Brown, MD, discuss surgical therapies for Crohn's disease and ulcerative colitis, including controversies about the best approaches.
Host Raymond Cross, MD, and colorectal surgeon Rebecca Brown, MD, discuss surgical therapies for Crohn's disease and ulcerative colitis, including controversies about the best approaches.
Host Raymond Cross, MD, brings in Dr Gursiman Kocchar to share his expertise in the management of strictures in Crohn's disease, from medical therapies to endoscopic procedures to surgery.
Host Raymond Cross, MD, brings in Dr Gursiman Kocchar to share his expertise in the management of strictures in Crohn's disease, from medical therapies to endoscopic procedures to surgery.
Dr Marla Dubinsky joins host Raymond Cross, MD, for a discussion about how inflammatory bowel disease affects women's reproductive health beyond childbearing, from choosing contraception and using hormonal replacement therapy in perimenopause.
Dr Marla Dubinsky joins host Raymond Cross, MD, for a discussion about how inflammatory bowel disease affects women's reproductive health beyond childbearing, from choosing contraception and using hormonal replacement therapy in perimenopause.
Drs Cross and Seminerio discuss advanced combination therapy, which involves use of more than one biologic or a biologic and an advanced small molecule, including trial results to date, types of combinations, safety considerations, and which...
Drs Cross and Seminerio discuss advanced combination therapy, which involves use of more than one biologic or a biologic and an advanced small molecule, including trial results to date, types of combinations, safety considerations, and which...
Drs Raymond Cross and Jordan Axelrad provide guidance to clinicians about the best ways to put risks—both of uncontrolled IBD and of therapies—into perspective for patients.
Drs Raymond Cross and Jordan Axelrad provide guidance to clinicians about the best ways to put risks—both of uncontrolled IBD and of therapies—into perspective for patients.
Host Raymond Cross, MD, calls on Dr Colleen Kelly to discuss the increasing prevalence of obesity among patients with IBD, how obesity can complicate Crohn's disease and ulcerative colitis, and the role of GLP-1 RAs and bariatric surgery in...
Host Raymond Cross, MD, calls on Dr Colleen Kelly to discuss the increasing prevalence of obesity among patients with IBD, how obesity can complicate Crohn's disease and ulcerative colitis, and the role of GLP-1 RAs and bariatric surgery in...
Drs Raymond Cross and Jared Magee discuss some of the special concerns that affect men with inflammatory bowel disease, from cardiac concerns to sexual dysfunction and assessing for anal cancer.
Drs Raymond Cross and Jared Magee discuss some of the special concerns that affect men with inflammatory bowel disease, from cardiac concerns to sexual dysfunction and assessing for anal cancer.